From Tumor Biology to Clinical Perspectives: Novel Biomarkers and Therapeutic Insights in Gastric Cancer
Xiya Cheng, Yunshu Ma, Jinglu Yan, Yizhe Zhang, Riguge Su, Xiaoming Tao, Jing Zhao, Peizhun Du · 2026
Read From Tumor Biology to Clinical Perspectives: Novel Biomarkers and Therapeutic Insights in Gastric Cancer by Xiya Cheng, Yunshu Ma, Jinglu Yan, Yizhe Zhang, Riguge Su, Xiaoming Tao, Jing Zhao, Peizhun Du (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13591360.txt.
Description
Xiya Cheng and co-authors review the hunt for better biomarkers and treatments in gastric cancer. Their 2026 review notes a hard reality: standard blood markers miss too many cases, and chemotherapy plus targeted drugs add only modest survival. Deep differences between and within tumors make the disease stubborn.
The survey ranges across gene and epigenetic changes, the signaling pathways they disturb, and the tumor's crowded microenvironment. It also covers the stomach's microbes and the inflammation they stir. From that biology the authors draw candidate markers for early detection, diagnosis, and risk sorting. Emerging therapies aimed at the new targets are weighed for promise. The review frames precision medicine as the destination, with biomarkers as the map still being drawn.
Catalog record
| CREATOR | Xiya Cheng, Yunshu Ma, Jinglu Yan, Yizhe Zhang, Riguge Su, Xiaoming Tao, Jing Zhao, Peizhun Du |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 83 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |